A host of evaluation methodologies are defining ‘value’ in drug prices
By Jason Shafrin, PhD, Precision Health Economics
Advertisement
Articles by By Jason Shafrin, PhD, Precision Health Economics
Advertisement
Latest Updated Articles
- Value frameworks are here: What to do about them?
Published: September 1st 2016 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
LogiPharma USA 2025: Pharma Supply Chains Evolve Toward Real-Time Visibility and End-to-End Control
2
Emotional Support as Strategy
3
Pharma Pulse: Novartis Buys Avidity for $12B, and Trump Threatens 10% Tariff Hike on Canada
4
Why DTC Drug Models Must Evolve From Access to True Patient Support
5
